Suppressor cells En

Fiche du sujet

Référentiel
Identifiant

Synonyme

T lymphocytes, Suppressor Cells, Suppressor Suppressor T lymphocytes

Discipline

Histoire, Philosophie et Sociologie des sciences (6) Histoire (1) Gestion et management (1) Economies et finances (1) Architecture, aménagement de l'espace (1) Archéologie et Préhistoire (1)

Type de document

Articles (16) Mémoires, Thèses et HDR (11) Recensions (6) Livres et chapitres d'ouvrages (1)

Auteur

Date

28 documents
Endothelial cell-derived oxysterol ablation attenuates experimental autoimmune encephalomyelitis.
F. Ruiz et al. (6 mars 2023)
Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies.
S. Domingos-Pereira et al. (21 déc. 2022)
The role of inducible costimulator in autoimmunity
Vincent Panneton (26 oct. 2022)
COVID-19 rapidly increases MDSCs and prolongs innate immune dysfunctions.
I.T. Schrijver et al.
Modulation of T cell receptor signals during thymic selection
Mengqi Dong (15 févr. 2022)
High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failure.
I.T. Schrijver et al. (11 févr. 2022)
Neutrophils in the era of immune checkpoint blockade.
J. Faget et al.
Le titre du document n'a pas été fourni à ISIDORE, pour consulter le document, cliquez ici
(12 févr. 2021)
Diagnostic profiling of MDSCs in sepsis
Irene T. Schrijver (2021)
Characterisation of immune-modulating lymphocyte populations in melanoma patients
Kaat de Jonge (21 juin 2019)
Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment.
H.S. Cheng et al. (30 mars 2019)
Myeloid-Derived Suppressor Cells in Sepsis.
I.T. Schrijver et al. (2019)
Rôle de CD271 dans l'immunomodulation des cellules T
Carole A. Bonkoungou (25 juil. 2018)
Prophylactic vs. Therapeutic Treatment With P2Et Polyphenol-Rich Extract Has Opposite Effects on Tumor Growth.
P. Lasso et al. (2018)
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.
S. Trabanelli et al. (19 sept. 2017)
ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence.
M.F. Chevalier et al. (2017)
Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don't Forget the Fuel.
M. Irving et al. (2017)
Immune infiltrate in sarcomas
M. RINGWALD (2015)
Étude de l’expression de la molécule d’adhérence CD146 dans les lymphocytes T
Cécile Grange (20 oct. 2014)
T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapy.
I. Melero et al. (2014)
Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab.
C. Meyer et al. (2014)
L’influence du réseau de chimiokines sur les lymphocytes T dans le contexte de l’infection à virus de l’immunodéficience humaine de type 1 (VIH-1)
Vanessa S. Wacleche (9 janv. 2013)
Therapeutic PD-1 pathway blockade augments with other modalities of immunotherapy T-cell function to prevent immune decline in ovarian cancer.
J. Duraiswamy et al. (2013)
Deciphering and reversing tumor immune suppression.
G.T. Motz et al. (2013)
Role of Myeloid-Derived Suppressor Cells in tumor-associated pregnancy
S. Waeber (2012)

next